Historical record - last NADAC publication: 2/17/2021
Product Information
NAPROXEN 375 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0736 per EA under NDC 69097085412. Its NADAC has been published 233 times since Sep 14, 2016.
The High Outlier badge above means this manufacturer's average price in the naproxen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
375 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085412
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/17/2021
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA091305On Market Since
7/5/2016
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 375 MG TABLET has been published 233 times since Sep 14, 2016, and over the history we have for it it has risen 33.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0736 per EA |
|---|---|
| All-time high | $0.0801 (Nov 13, 2019) |
| All-time low | $0.0548 (Jul 19, 2017) |
| Median price | $0.0643 |
| Average price | $0.0664 |
| Largest weekly change | +14.4% (Apr 17, 2019) |
| Weeks tracked | 233 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NAPROXEN 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Cipla USA Inc., is $0.0736 per EA (NDC 69097085412), effective Feb 24, 2021.
How has the price of NAPROXEN 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has risen 33.4%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?
Since Sep 14, 2016, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0548 (Jul 19, 2017) to a high of $0.0801 (Nov 13, 2019), with a median of $0.0643 per EA.
Are there cheaper alternatives to NAPROXEN 375 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as NAPROXEN 375 MG TABLET, but none are currently priced below it.
Who manufactures NAPROXEN 375 MG TABLET?
NAPROXEN 375 MG TABLET (NDC 69097085412) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification